HUMAN GENE TRANSFER/THERAPY PROTOCOL 
9209-027 
9209-028 
9209-029 
Schuening, Friedrich G., Fred Hutchinson Cancer Research Center; 
Phase I /I I Study of the Use of Recombinant Human Interleukin 3 (rhil3) 
Stimulated Peripheral Blood Progenitor Cell Supplementation in 
Autologous Bone Marrow Transplantation in Patients with Breast 
Carcinoma or Hodgkin 's Disease. 
Date of RAC Approval: 9/14/92 
Schuening, Friedrich G., Fred Hutchinson Cancer Research Center; 
Evaluation of the Use of Recombinant Human G-CSF Stimulated 
Peripheral Blood Progenitor Cell Supplementation in Autologous Bone 
Marrow Transplantation in Patients with Lymphoid Malignancies. 
Date of RAC Approval: 9/14/92 
Schuening, Friedrich G., Fred Hutchinson Cancer Research Center; A 
Trial of G-CSF Stimulated Peripheral Blood Stem Cells for Engraftment 
in Identical Twins. 
Date of RAC Approval: 9/14/92 
[330] 
Recombinant DNA Research, Volume 16 
